About

Dr. Borja del Carmelo Gracia Tello is an internist and academic director of the Unidad de Enfermedades Autoinmunes Sistémicas (Systemic Autoimmune Diseases Unit) at Hospital Clínico Universitario Lozano Blesa (Zaragoza), and Professor of Medicine at the University of Zaragoza. After completing his specialist training in Internal Medicine, he undertook a research fellowship with Prof. David Isenberg at University College London, where he gained advanced expertise in systemic autoimmune diseases and lupus. His clinical and research work focuses on microvascular involvement and connective tissue diseases, with a particular interest in systemic sclerosis, biomarkers of disease activity, and imaging-based tools to improve early diagnosis and risk stratification.

Dr. Gracia Tello has coordinated and participated in multiple national and international research projects, including studies on systemic sclerosis–associated pulmonary arterial hypertension, sarcoidosis, giant cell arteritis, and COVID-19. He is the lead inventor of a project on the digitalisation and automated analysis of nailfold capillaroscopy, developed through the GEAS (Grupo Español de Enfermedades Autoinmunes Sistémicas) of SEMI (Spanish Society of Internal Medicine), and co-author of the CAPI-Score and CAPI-Detect algorithms for quantitative videocapillaroscopy. As Chair of the Scientific Advisory Board, he provides strategic and scientific oversight for Capillaroscopy.com, ensuring that all educational content is rigorous, up-to-date, and aligned with international standards of care.

Eduardo Ramos Ibáñez is a software engineer specialized in machine learning and deep learning, with a degree in Computer Engineering from the University of Zaragoza. As founder and CTO of Capillary.io, he leads the technical strategy and development of an AI-driven software platform for nailfold videocapillaroscopy, designed to help clinicians standardize, accelerate and improve the quality of capillaroscopic examinations.

He has collaborated closely with Dr. Borja del Carmelo Gracia Tello and other clinical experts to translate capillaroscopy expertise into robust algorithms and practical tools for routine use. Eduardo is co-author of several peer-reviewed publications in the field of capillaroscopy, including work on comprehensive videocapillaroscopy practice, clinical validation of automated image analysis software, and the development of quantitative algorithms such as CAPI-Score and CAPI-detect for objective capillaroscopy.

Dr. Gema María Lledó Ibáñez is a specialist in Internal Medicine and Rheumatology at Hospital Regional Universitario Carlos Haya de Málaga. Her clinical work focuses on the diagnosis and longitudinal management of connective tissue diseases and other systemic autoimmune disorders, with particular interest in microvascular involvement.

She is a project coordinator of the CapIAMI (Capillaroscopy and Artificial Intelligence in Inflammatory Myopathies) study, a multicenter observational project that analyzes capillaroscopic abnormalities in idiopathic inflammatory myopathies using artificial intelligence. The study aims to describe and quantitatively characterize these abnormalities, and to explore correlations with clinical manifestations, specific autoantibodies, and prognosis.

As an advisory board member, Dr. Lledó Ibáñez contributes her clinical and research experience to the development and review of educational content, helping ensure that materials remain practical, evidence-based, and closely aligned with real-world rheumatology practice.

Dr. Jorge Álvarez Troncoso is a specialist in Internal Medicine at Hospital Universitario La Paz (Madrid), with clinical activity focused on systemic autoimmune diseases and complex multisystem conditions. He is project coordinator, together with Dr. Gema María Lledó Ibáñez, of the CapIAMI (Capillaroscopy and Artificial Intelligence in Inflammatory Myopathies) study, a multicenter observational project that analyzes capillaroscopic abnormalities in idiopathic inflammatory myopathies using artificial intelligence.

As an advisory board member, Dr. Álvarez Troncoso contributes his experience in systemic disease and clinical research to ensure that the educational content remains rigorous, clinically relevant, and aligned with current evidence.